Terence A. Ketter, MD

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.

Stanley N. Caroff, Leslie Citrome, Jonathan Meyer, et al

Letter to the Editor

Sensitive and Personalized Determinations of Likelihood of Being Helped or Harmed

May 24, 2017

Terence A. Ketter, Leslie Citrome

Original Research

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

January 27, 2016

Thilo Deckersbach, Andrew A. Nierenberg, Melvin G. McInnis, et al

Original Research

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

January 27, 2016

Andrew A. Nierenberg, Susan L. McElroy, Edward S. Friedman, et al

Letter to the Editor

Number Needed to Treat Can Be Helpful: A Response to Andrade

September 23, 2015

Leslie Citrome, Terence A. Ketter

Consensus Statement

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

March 25, 2015

Katherine E. Burdick, Terence A. Ketter, Joseph F. Goldberg, et al

ASCP Corner

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

January 28, 2015

Terence A. Ketter, Po W. Wang, Shefali Miller

Original Research

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

July 22, 2014

Joseph R. Calabrese, Mark A. Frye, Ronghua Yang, et al

Commentary

Update on Best Practices for Managing Bipolar Depression

May 15, 2014

Gary S. Sachs, Terence A. Ketter

Educational Activity

Acute and Maintenance Treatments for Bipolar Depression

April 15, 2014

Terence A. Ketter

Educational Activity

Important Distinctions Between Bipolar I and Bipolar II Depression

August 15, 2013

Terence A. Ketter

ASCP Corner

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

June 15, 2013

Shefali Miller, Kiki D. Chang, Terence A. Ketter

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Sensitive and Personalized Determinations of Likelihood of Being Helped or Harmed

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Number Needed to Treat Can Be Helpful: A Response to Andrade

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Update on Best Practices for Managing Bipolar Depression

Acute and Maintenance Treatments for Bipolar Depression

Important Distinctions Between Bipolar I and Bipolar II Depression

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

ELSEWHERE:

FOLLOW US:

Terence A. Ketter, MD

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Sensitive and Personalized Determinations of Likelihood of Being Helped or Harmed

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Number Needed to Treat Can Be Helpful: A Response to Andrade

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Update on Best Practices for Managing Bipolar Depression

Acute and Maintenance Treatments for Bipolar Depression

Important Distinctions Between Bipolar I and Bipolar II Depression

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles